title: Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cells via a serum-dependent cytotoxic pathway.
abstract: An in vitro blood-brain barrier (BBB) model consisting of primary cultures of bovine brain microvascular endothelial cells was used to examine the effect of Haemophilus influenzae type b (Hib) on the BBB. Whole bacteria and purified lipopolysaccharide (LPS; greater than 10 ng/ml) caused marked cytotoxicity on the bovine brain endothelial cells. This effect could be completely blocked by polymyxin B. Similar cytotoxic effects were observed with a cultured bovine pulmonary endothelial cell line. Serum was essential for the LPS-mediated cytotoxic effect, and human, horse, bovine, or fetal calf serum all had similar effects. The serum factor was not a complement component. A monoclonal antibody against CD14, a receptor involved in mediating the effect of LPS in monocytes, completely blocked the cytotoxic effect in both brain and pulmonary endothelial cells. These results suggest that Hib LPS disrupts an in vitro BBB model via a serum- and CD14-dependent pathway and that LPS has cytotoxic effects on bovine endothelial cells without the involvement of monocytic cells, an effect that may be important in gram-negative meningitis and in endotoxic shock.
authors.affiliation: Department of Biochemistry, University of British Columbia, Vancouver, Canada.
authors.forename: D
authors.initials: D
authors.lastname: Patrick
authors.forename: J
authors.initials: J
authors.lastname: Betts
authors.forename: E A
authors.initials: EA
authors.lastname: Frey
authors.forename: R
authors.initials: R
authors.lastname: Prameya
authors.forename: K
authors.initials: K
authors.lastname: Dorovini-Zis
authors.forename: B B
authors.initials: BB
authors.lastname: Finlay
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D015703:Antigens, CD / Q000276:immunology; D015214:Antigens, Differentiation, Myelomonocytic / Q000276:immunology; D001812:Blood-Brain Barrier / Q000187:drug effects*; D002417:Cattle; D002460:Cell Line; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000098:blood supply*; D003602:Cytotoxicity, Immunologic; D004730:Endothelium, Vascular / Q000166:cytology* / Q000382:microbiology / Q000648:ultrastructure; D005455:Fluorescent Antibody Technique; D006193:Haemophilus influenzae; D007106:Immune Sera / Q000276:immunology; D007365:Intercellular Junctions / Q000648:ultrastructure; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides / Q000276:immunology*; D008833:Microcirculation; D008854:Microscopy, Electron; D008855:Microscopy, Electron, Scanning; D008858:Microscopy, Phase-Contrast; D011112:Polymyxin B / Q000494:pharmacology
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D007106:Immune Sera; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D011112:Polymyxin B